TruSight Oncology 500 v2 DNA/RNA Automation Kit, For Use with NextSeq 1000/2000 P2 (32 samples)
Vendor: Illumina
SKU: 20138678
In stock
Includes reagents for preparing and enriching up to 32 DNA and RNA samples, and NextSeq 1000/2000 P2 sequencing reagents. Purchase indexes separately. Intended for use with automation.
TruSight Oncology 500 v2 is a pan-cancer next-generation sequencing (NGS) assay that enables in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue for oncology research.
Documents
- Analysis of TMB and MSI Status with TruSight Oncology 500
- Input Recommendations for TMB, MSI, and Small Variant Analysis with TruSight Oncology 500
- TruSight Oncology 500 Gene List - English
- TruSight Oncology 500 Gene List - Chinese (Simplified)
- TruSight Oncology 500 and TruSight Oncology 500 High-Throughput
- Data analysis and reporting for the TruSight Oncology 500 portfolio
- Chinese (Simplified)
- TruSight Oncology 500 portfolio
Support Documentation
Specifications
- Area of interest Cancer research, Drug discovery & development, Immuno-oncology research, Immunology
- Assay time 3–4 days from sample input to final results
- Automation capability Liquid handling robot(s)
- Cancer type Pan-cancer, Solid tumor
- Content specifications Targeted sequencing of DNA from 523 genes and RNA from 55 genes for a total of 1.94 Mb panel size. MSI and TMB measurement included. The included HRD panel † includes coverage of ~25K SNPs to assess homologous recombination deficiency through a comprehensive genomic instability score (LOH+TAI+LST) powered by Myriad Genetics. † TruSight Oncology 500 v2 is not available for sale in Japan
- Hands on time ~3.25 hrs for automated workflow ~5-7 hrs for manual workflow
- Input quantity 30 ng DNA (as low as 10 ng), 40 ng RNA (as low as 20 ng)
- Instruments NextSeq 1000 SystemNextSeq 2000 SystemNextSeq 550 SystemNextSeq 550Dx in Research ModeNovaSeq 6000 SystemNovaSeq 6000Dx in Research ModeNovaSeq X Plus SystemNovaSeq X System
- Key use Targeted analysis, Tumor immunogenicity analysis
- Method Target enrichment, Targeted DNA sequencing, Targeted RNA sequencing
- Multiplexing NextSeq 550/Dx: 8 samples/run. NexSeq 1000 and 2000: P2 flow cell 8 samples, P3 flow cell 24 samples, P4 flow cell 36 samples. NovaSeq 6000/Dx: SP flow cell 16 samples, S1 flow cell 32 samples, S2 flow cell 72 samples, S4 flow cell 192 samples. NovaSeq X/X+: 1.5 B 32 samples, 10B 192 samples, 25B 480 samples.
- Nucleic acid type DNA, RNA
- Specialized sample types FFPE tissue
- Species category Human
- Technology Sequencing
- Variant class Copy number variants (CNVs), Gene fusions, Genomic instability score (GIS), Insertions-deletions (indels), Loss of heterozygosity (LOH), Microsatellite instability (MSI), Multi-nucleotide variants (MNVs), Single nucleotide variants (SNVs), Somatic variants, Transcript variants, Tumor mutational burden (TMB)
links and documants
- Datasheet url Click here
- Source url Click here
Couldn't load pickup availability
TruSight Oncology 500 v2 DNA/RNA Automation Kit, For Use with NextSeq 1000/2000 P2 (32 samples)
Quick order list
Free shipping on almost everything
Free Shipping
All orders over $500 are delivered to your doorstep at no extra charge.
30-Days Free Returns
Enjoy the freedom of stress-free shopping with our hassle-free and return policy.
Secure Payment
Shop with confidence knowing your payments are secure and your information

